MAP3K13/LZK Polyclonal Antibody, PE Conjugated
Product Specifications
Background
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.
Synonyms
Mitogen-activated protein kinase kinase kinase 13; MAP3K13; Leucine zipper-bearing kinase; Mixed lineage kinase; MLK; LZK
Gene ID
9175
Swiss Prot
O43283
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse
Immunogen
801-900/966
Target
MAP3K13/LZK
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE
Source
KLH conjugated synthetic peptide derived from human MAP3K13
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
496,564nm/578nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
9175
Predicted Cross Reactivity
Cow
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL701186V 500 µL Each
Vom1r42 Rat shRNA Lentiviral Particle (Locus ID 494303)
Sign In for Pricing
View Details 
TR310566 1 Kit
Proprotein Convertase 2 (PCSK2) Human shRNA Plasmid Kit (Locus ID 5126)
Sign In for Pricing
View Details